Hims & Hers与诺和诺德结束诉讼,Hims将停止推广复方胰高血糖素样肽-1药物,并通过其平台提供威戈维和奥泽匹克;Hims股价大涨。
海量资讯、精准解读,尽在新浪财经APP
责任编辑:张俊 SF065
Hims & Hers与诺和诺德结束诉讼,Hims将停止推广复方胰高血糖素样肽-1药物,并通过其平台提供威戈维和奥泽匹克;Hims股价大涨。
责任编辑:张俊 SF065
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.